Getein1600 Immunofluorescence Quantitative Analyzer (hereinafter called Getein1600) is a fully-automatic analyzer for processing and analysis of Getein test kits including markers for cardiovascular diseases, renal diseases, inflammation, fertility, diabetes mellitus, bone metabolism, tumor and thyroid. Getein1600 is used to measure concentration of biomarkers in human whole blood, serum, plasma or urine samples. The results can be used as an aid in clinical diagnosis of laboratory and point of care testing.
▶ Intellectualized Software System
-User-friendly interface -Diversified test modes: random, batch, STAT
▶ High Throughput
-48 Samples per run
-Continuous loading of different test items
-Up to 150 tests/hour
▶ Traceability of Results
-Automatic barcode scanning of test items
-Automatic recognition of reagents
▶ Simple Operation
-Real-time monitoring of samples and consumables
-Visualized reagent interface
▶ Accurate and Reliable Test Results
-Fully automatic sample adding
-Disposable tips with filter elements, which avoid cross-contamination -Automatic calibration, dilution and sample loading
-Fully-automatic quality control
▶ Easy for Standardized Management
-Fully-automatic sample loading and detection -Standard SOP documented
-Meet the requirements of clinical laboratory standards
Getein Biotech, Inc. is a Nanjing headquartered and globally operated in-vitro diagnostic company founded in 2002, which is specialized in developing, manufacturing and marketing in-vitro diagnostic reagents and medical devices.
Getein has developed 5 technology platforms including colloidal gold immunochromatography, fluorescence immunochromatography, biochemical latex reagents,chemiluminescence, and raw materials for diagnostic reagents. Sequentially, Getein achieved the Rheinland TÜV ISO 13485 Quality Management System Certification and CE Certification, ensuring the quality, stability and reliability of the products. International marketing network has been built by subsidiaries and offices all over the world, which helps to the sales of premium products to more than 80 countries.
Until now, Getein has more than 160 products with intellectual property rights, covering multiple fields including cardiovascular disease, kidney injury, diabetes mellitus, gestation, infectious disease, cancer, etc.
Getein is devoted to providing more accurate and reliable products, as well as expanding product portfolio in chemiluminescence and molecular diagnosis in the future.